Wei Li

机构：Zhejiang International Studies University, Jilin University, Sichuan University, Xinjiang Production and Construction Corps, Guangzhou First People's Hospital, Wuyi University, First Affiliated Hospital of Jinan University, Beihang University, Guangzhou Medical University · ORCID：0000-0001-7850-9999

发表论文 47 篇 · 总被引 375 次 · h-index 10

代表论文

• Sinomenine protects against atherosclerosis in apolipoprotein E-knockout mice by inhibiting of inflammatory pathway (2024 · Inflammopharmacology · 被引 13)
• Disordered gut microbiota and alterations in the serum metabolome are associated with venous thromboembolism (2024 · Thrombosis Research · 被引 11)
• First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up of Chinese pts from CheckMate 649. (2025 · Journal of Clinical Oncology · 被引 7)
• Intravenous thrombolysis versus dual antiplatelet therapy in minor ischemic stroke within the thrombolytic window (TAMIS): a multicenter cohort study (2024 · Journal of Thrombosis and Thrombolysis · 被引 5)
• A Comprehensive Analysis of the Association Between the EORTC QLQ‐C30 Questionnaire and Cachexia in Patients With Gastric Cancer (2025 · Journal of Cachexia Sarcopenia and Muscle · 被引 3)
• Palmitic acid-evoked PKR/JNK activation and SIRT1 decline: Association with myocardial ageing phenotype changes and partial reversal by inhibitors (2026 · Tissue and Cell · 被引 2)